Literature DB >> 30001782

Sarcopenia: A Rheumatic Disease?

Sarthak Gupta1, Robinder J S Dhillon1, Sarfaraz Hasni2.   

Abstract

Sarcopenia refers to the age-related loss of muscle mass, muscle strength, and physical function. With an increase in the number and proportion of elderly in the population, sarcopenia is a growing global health concern due to its impact on morbidity, mortality, and health care expenditure. Despite its clinical importance, sarcopenia remains underrecognized and poorly managed in routine clinical practice. This is, in part, due to a lack of available diagnostic testing and uniform diagnostic criteria. This article provides the general practitioner or rheumatologist an overview of the pathophysiology, diagnosis, and management of this complex and critical entity. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Fall risk; Frailty; Muscle atrophy; Muscle strength; Sarcopenia; Senescence; Skeletal muscle mass loss

Mesh:

Year:  2018        PMID: 30001782      PMCID: PMC6047534          DOI: 10.1016/j.rdc.2018.03.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  60 in total

Review 1.  Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.

Authors:  James G Ryall; Jonathan D Schertzer; Gordon S Lynch
Journal:  Biogerontology       Date:  2008-02-26       Impact factor: 4.277

2.  The numbers of limb motor neurons in the human lumbosacral cord throughout life.

Authors:  B E Tomlinson; D Irving
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

3.  Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.

Authors:  Clemens Becker; Stephen R Lord; Stephanie A Studenski; Stuart J Warden; Roger A Fielding; Christopher P Recknor; Marc C Hochberg; Serge L Ferrari; Hubert Blain; Ellen F Binder; Yves Rolland; Serge Poiraudeau; Charles T Benson; Stephen L Myers; Leijun Hu; Qasim I Ahmad; Kelli R Pacuch; Elisa V Gomez; Olivier Benichou
Journal:  Lancet Diabetes Endocrinol       Date:  2015-10-27       Impact factor: 32.069

4.  Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients.

Authors:  M J Santos; F Vinagre; J Canas da Silva; V Gil; J E Fonseca
Journal:  Clin Exp Rheumatol       Date:  2011-06-29       Impact factor: 4.473

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 6.  The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Charlotte Beaudart; Fanny Buckinx; Véronique Rabenda; Sophie Gillain; Etienne Cavalier; Justine Slomian; Jean Petermans; Jean-Yves Reginster; Olivier Bruyère
Journal:  J Clin Endocrinol Metab       Date:  2014-07-17       Impact factor: 5.958

7.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

8.  A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

Authors:  D A Papanicolaou; S N Ather; H Zhu; Y Zhou; J Lutkiewicz; B B Scott; J Chandler
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

9.  Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

Authors:  Abdellah El Maghraoui; François Bertin Ebo'o; Siham Sadni; Abderrahim Majjad; Toufik Hamza; Aziza Mounach
Journal:  BMC Musculoskelet Disord       Date:  2016-07-11       Impact factor: 2.362

10.  An evidence-based comparison of operational criteria for the presence of sarcopenia.

Authors:  Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  4 in total

1.  Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study.

Authors:  Xingcai Chen; Cunqing Kong; Hongrong Yu; Jiangu Gong; Ling Lan; Lining Zhou; Jichun Gong; Peng Liu; Lin Xu; Qiongying Deng
Journal:  BMJ Open       Date:  2019-07-18       Impact factor: 2.692

2.  Sarcopenia May Be a Risk Factor for Osteoporosis in Chinese Patients with Rheumatoid Arthritis.

Authors:  Li Lian; Jian-Xiong Wang; Yue-Chen Xu; He-Xiang Zong; Yu-Zhu Teng; Sheng-Qian Xu
Journal:  Int J Gen Med       Date:  2022-02-23

Review 3.  Sarcopenia in rheumatic disorders: what the radiologist and rheumatologist should know.

Authors:  Wilfred Manzano; Leon Lenchik; Akshay S Chaudhari; Lawrence Yao; Sarthak Gupta; Robert D Boutin
Journal:  Skeletal Radiol       Date:  2021-07-16       Impact factor: 2.199

4.  Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.

Authors:  Carola Hedberg-Oldfors; Ulrika Lindgren; Swaraj Basu; Kittichate Visuttijai; Christopher Lindberg; Maria Falkenberg; Erik Larsson Lekholm; Anders Oldfors
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.